Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 400 of 6351
-
Acupuncture needles take on sickle cell pain: new study tests brain impact
Symptom relief Recruiting nowThe proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.
Sponsor: University of Cincinnati • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New hope for bile duct cancer: combo therapy aims to boost survival
Disease control Not yet recruitingThe goal of this clinical trial is to etablish whether adding Mitazalimab to standard chemotherapy is more effective than standard chemotherapy alone in people with advanced bile duct cancer. It will also learn about the safety of Mitazalimab. The main questions it aims to answe…
Phase 2/3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Cord tissue patches aim to heal stubborn diabetic foot sores
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy of two dehydrated human umbilical cord-based medical devices, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ul…
Sponsor: StimLabs • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New eye injection could mean fewer doctor visits for wet AMD patients
Disease control Not yet recruitingThe goal of this study is to evaluate whether AIV007 provides benefits to patients with neovascular age-related macular degeneration in improving vision and that it has an acceptable safety profile. Participants will receive either a periocular injection of AIV007 or intravitrea…
Phase 2 • Sponsor: AiViva BioPharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Triple-Drug attack before lung surgery shows promise in early trial
Disease control Not yet recruitingAlthough phase III studies have confirmed the efficacy and safety of perioperative immunotherapy plus chemotherapy for resectable NSCLC, there remains room for improvement in both short-term efficacy and long-term survival. Preclinical evidence suggests that PCSK-9 inhibition may…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New trial aims to shield hearts from chemo side effects
Prevention Not yet recruitingThis project aims to determine the benefits of the dual SGLT1/2 inhibition as prophylactic treatment to prevent anthracycline-related cardiotoxicity.
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Could a cancer drug stop a deadly complication in transplant patients?
Prevention Not yet recruitingPeople who have received a solid organ transplant can develop ongoing Epstein-Barr virus (EBV) infection in the blood, which increases the risk of a serious cancer called post-transplant lymphoproliferative disorder (PTLD). This study will test whether rituximab, a drug approved …
Phase 1 • Sponsor: Jennifer Amengual • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Promising drug cocktail targets Hard-to-Treat lung cancer
Disease control Not yet recruitingThis is a phase II trial in patients with locally advanced or metastatic non-small cell lung cancer harboring HER2 gene abnormalities (amplification or overexpression)with a performance status of 0 to1 who are planned to receive first-line treatment or who have falied the first-l…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Oxygen-Boosting injection may help rectal cancer patients avoid surgery
Disease control Not yet recruitingThis phase II clinical trial is evaluating whether adding KRC-01 injections to standard chemoradiotherapy may improve treatment outcomes in patients with locally advanced rectal cancer without metastases. KRC-01 is an investigational product designed to improve the effectiveness…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill targets hard-to-treat cancers with KRAS G12D mutation
Disease control Not yet recruitingThis study is to evaluate the safety and tolerability of of LT-010391 as monotherapy in participants with KRAS G12D mutant advanced solid tumors
Phase 1 • Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Tailored drug cocktails aim to outsmart resistant esophageal cancer
Disease control Not yet recruitingThis study is an open-label, biomarker-integrated umbrella trial designed to evaluate the clinical efficacy of molecular subtype- and genomic biomarker-guided precision therapies in patients with advanced esophageal cancer refractory to prior immunotherapy. Conducted in a two-ste…
Phase 2/3 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New blood test could prevent dangerous delays in preeclampsia deliveries
Disease control Not yet recruitingPreeclampsia is a serious pregnancy complication caused by abnormal placental development and function. It can lead to high blood pressure and damage to organs such as the liver, kidneys, brain, or cardiovascular system. In these cases, the only definitive treatment is delivery. …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Promising drug cocktail aims to save voice boxes in throat cancer patients
Disease control Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of Becotatug Vedotin (EGFR-ADC) in combination with Pucotenlimab(Anti-PD-1 Monoclonal Antibody) as neoadjuvant therapy for patients with Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma. The primary o…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
AI could help doctors pick better diabetes drugs
Disease control Not yet recruitingThis study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for their patients. Type 2 diabetes is very common, but there are far more patients than diabetes specialists, so many patients are treated by doctors who are not diabe…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a diabetes drug boost pregnancy success in women with PCOS?
Disease control Not yet recruitingThe goal of this clinical trial is to examine whether GLP1-RA and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle …
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Heart failure hope: gut bacteria and drug combo tested in seniors
Disease control Not yet recruitingHFpEF has a high incidence and lacks effective therapy, and its onset is closely related to systemic inflammation and intestinal dysbacteriosis.SGLT-2i exerts its effects by diuresis, anti-inflammatory and improving energy metabolism, whereas probiotics modulate intestinal flora,…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Air Force Medicial University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental drug combo targets Hard-to-Treat head and neck cancer
Disease control Not yet recruitingThis is a single-center, open-label phase 2 study evaluating sacituzumab tirumotecan in combination with an immune checkpoint inhibitor in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma. Eligible patients will have recurrent or met…
Phase 2 • Sponsor: Biying Chen • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can an app heal the hidden wounds of prostate cancer?
Symptom relief Recruiting nowProstate cancer (PCa) survivors frequently experience enduring psychosexual challenges following treatment, including sexual dysfunction, emotional distress, and reduced quality of life. Despite these difficulties, access to tailored support remains limited, highlighting the need…
Sponsor: Universidade do Porto • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Can a single spinal injection transform Post-Surgery pain relief?
Symptom relief Recruiting nowThis study aims to compare the efficacy of intrathecal morphine and intrathecal dexmedetomidine in reducing pain following lumbar spine fixation surgeries.
Sponsor: Tanta University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can adding exercise or physical therapy to steroid injections better ease chronic neck pain?
Symptom relief Recruiting nowChronic neck pain can negatively affect daily activities, work ability, and quality of life. Cervical epidural block is commonly used to reduce pain and inflammation, while exercise and physical therapy aim to improve muscle strength, endurance, movement control, and physical fun…
Sponsor: Alİ Eman, MD • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC